The halal nutraceuticals and vaccines market is on the brink of transformative growth, with an estimated valuation of USD 137,390.9 million by 2033. This market segment, driven by consumer demand for halal-certified products, is poised to redefine the nutraceutical and vaccine landscape. Suppliers can anticipate a steady compound annual growth rate (CAGR) of 7.6% from …